The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Clinical Importance of Adherence to Treatment With Eicosapentaenoic Acid by Patients With Hypercholesterolemia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adherence was lower in the intervention group (66.5%)”
From Interventions to improve adherence among patients prescribed statins for primary prevention of cardiovascular diseases: a systematic review and meta-analysis (2026) · cites this paper as Origasa et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Medication compliance and persistence: terminology and definitions
Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353 · cited 4×
“Smoker 542 (21) 1,158 (17) 662 (21) 1,168 (19)”
InfluentialInterventions to Enhance Patient Adherence to Medication Prescriptions: Scientific Review
McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002) · JAMA · doi:10.1001/jama.288.22.2868 · Cited by 1,176
Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.003 · Cited by 316
Self-citation
Research works printed but not linked: 33
- 1. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-1307. · DOI · Paper page
- 10.1016/S0140-6736(06)69472-5 · DOI · Paper page
- 10.1016/S0140-6736(07)60527-3 · DOI · Paper page
- 4. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: The heart and soul study. Arch Intern Med 2007; 167: 1798-1803. · DOI · Paper page
- 5. Bennett SJ, Huster GA, Baker SL, Milgrom LB, Kirchgassner A, Birt J, et al. Characterization of the precipitants of hospitalization for heart failure decompensation. Am J Crit Care 1998; 7: 168-174. · DOI · Paper page
- 6. Carlson B, Riegel B, Moser DK. Self-care abilities of patients with heart failure. Heart Lung 2001; 30: 351-359. · DOI · Paper page
- 7. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure: Traits among urban blacks. Arch Intern Med 1988; 148: 2013-2016. · DOI
- 8. Fletcher SW, Pappius EM, Harper SJ. Measurement of medication compliance in a clinical setting: Comparison of three methods in patients prescribed digoxin. Arch Intern Med 1979; 139: 635-638. · DOI
- 9. Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1980; 303: 1038-1041. · DOI · Paper page
- 10.1016/0140-6736(90)92095-Y · DOI · Paper page
- 11. The West of Scotland Coronary Prevention Study Group. Compliance and adverse event withdrawal: Their impact on the West of Scotland Coronary Prevention Study. Eur Heart J 1997; 18: 1718-1724. · DOI
- 12. Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006; 166: 1842-1847. · DOI · Paper page
- 13. Rudnicka AR, Ashby D, Brennan P, Meade T. Thrombosis prevention trial: Compliance with warfarin treatment and investigation of a retained effect. Arch Intern Med 2003; 163: 1454-1460. · DOI
- 10.1016/S0140-6736(03)14282-1 · DOI · Paper page
- 15. Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, for the CHARM Investigators. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: Double-blind, randomized, controlled clinical trial. Lancet 2005; 366: 2005-2011. · DOI · Paper page
- 16. Brown SB, Shannon RP. Improving medication compliance in patients with heart failure. Am J Cardiol 2008; 101: 274-277. · DOI
- 19. Jerant A, DiMatteo R, Arnsten J, Moore-Hill M, Franks P. Self-report adherence measures in chronic illness: Retest reliability and predictive validity. Med Care 2008; 46: 1134-1139. · DOI
- 10.1016/S0002-8703(03)00367-3 · DOI
- 10.1253/circj.CJ-09-0331 · DOI
- 10.1253/circj.CJ-09-0327 · DOI
- 10.1253/circj.CJ-08-0249 · DOI
- 10.1016/j.jclinepi.2007.04.007 · DOI
- 25. Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y, Edelstein S, et al for the Diabetes Prevention Program Research Group. Adherence to preventive medications: Predictors and outcomes in the Diabetes Prevention Program. Diabetes Care 2006; 29: 1997-2002. · DOI · Paper page
- 26. Qureshi NN, Hatcher J, Chaturvedi N, Jafar TH, for the Hypertension Research Group. Effect of general practitioner education on adherence to antihypertensive drugs: Cluster randomized controlled trial. BMJ 2007; 335: 1030-1033. · DOI
- 27. Daskalopoulou SS, Delaney JA, Filion KB, Brophy JM, Mayo NE, Suissa S. Discontinuation of statin therapy following an acute myocardial infarction: A population-based study. Eur Heart J 2008; 29: 2083-2091. · DOI
- 10.1253/circj.CJ-08-1197 · DOI
- 30. Nielsen MW, Søndergaard B, Kjøller M, Hansen EH. Agreement between self-report data on medicine use and prescription records vary according to method of analysis and therapeutic group. J Clin Epidemiol 2008; 61: 919-924. · DOI
- 31. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006; 15: 565-574. · DOI · Paper page
- 32. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke HC. Compliance with secondary prevention of ischemic stroke: A prospective evaluation. Stroke 2001; 32: 1884-1889. · DOI
- 10.1001/jama.288.22.2880 · DOI · Paper page
- 35. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: A randomized controlled trial. JAMA 2006; 296: 2563-2571. · DOI · Paper page
- 36. Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, et al. Pharmacist intervention to improve medication adherence in heart failure: A randomized trial. Ann Intern Med 2007; 146: 714-725. · DOI · Paper page
- 37. Gwadry-Sridhar F, Guyatt G, O'Brien B, Arnold JM, Walter S, Vingilis E, et al. TEACH: Trial of Education And Compliance in Heart dysfunction chronic disease and heart failure (HF) as an increasing problem. Contemp Clin Trials 2008; 29: 905-918. · DOI
Cited by
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub3 · Cited by 630
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub4 · Cited by 405
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review
Delgado-Lista, J., Perez-Martinez, P., Lopez-Miranda, J., & Perez-Jimenez, F. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001596 · Cited by 351
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 302
Metadata
- Authors
- Origasa, H., Yokoyama, M., Matsuzaki, M., Saito, Y., Matsuzawa, Y., & The JELIS Investigators
- Affiliations
- Division of Biostatistics and Clinical Epidemiology, University of Toyama School of Medicine
- Hyogo Prefectural Awaji Hospital
- Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine
- Chiba University
- Sumitomo Hospital
- Venue
- Circulation Journal
- Publisher
- Japanese Circulation Society
- Published
- 2010
- Volume
- 74
- Issue
- 3
- Pages
- 510-517
- ISSN
- 1346-9843
- 1347-4820
- Cited by
- 32
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.